- Home
- IVDA vs QNRX Comparison
IVDA vs QNRX Comparison
Compare IVDA & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- QNRX
- Stock Information
- Founded
- IVDA 2003
- QNRX 2018
- Country
- IVDA United States
- QNRX United States
- Employees
- IVDA N/A
- QNRX N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- QNRX Medical/Dental Instruments
- Sector
- IVDA Technology
- QNRX Health Care
- Exchange
- IVDA Nasdaq
- QNRX Nasdaq
- Market Cap
- IVDA 4.3M
- QNRX 4.8M
- IPO Year
- IVDA N/A
- QNRX N/A
- Fundamental
- Price
- IVDA $1.33
- QNRX $13.03
- Analyst Decision
- IVDA
- QNRX
- Analyst Count
- IVDA 0
- QNRX 0
- Target Price
- IVDA N/A
- QNRX N/A
- AVG Volume (30 Days)
- IVDA 5.1M
- QNRX 833.5K
- Earning Date
- IVDA 11-13-2025
- QNRX 11-07-2025
- Dividend Yield
- IVDA N/A
- QNRX N/A
- EPS Growth
- IVDA N/A
- QNRX N/A
- EPS
- IVDA N/A
- QNRX N/A
- Revenue
- IVDA $7,142,302.00
- QNRX N/A
- Revenue This Year
- IVDA $340.48
- QNRX N/A
- Revenue Next Year
- IVDA N/A
- QNRX N/A
- P/E Ratio
- IVDA N/A
- QNRX N/A
- Revenue Growth
- IVDA 88.96
- QNRX N/A
- 52 Week Low
- IVDA $1.15
- QNRX $5.01
- 52 Week High
- IVDA $8.05
- QNRX $48.30
- Technical
- Relative Strength Index (RSI)
- IVDA 46.08
- QNRX 54.33
- Support Level
- IVDA $1.18
- QNRX $12.00
- Resistance Level
- IVDA $1.34
- QNRX $17.84
- Average True Range (ATR)
- IVDA 0.13
- QNRX 4.54
- MACD
- IVDA -0.01
- QNRX -0.02
- Stochastic Oscillator
- IVDA 30.86
- QNRX 16.87
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.